Cyclophosphamide-Induced Late-Onset Lung Disease.

Internal Medicine - Japan
doi 10.2169/internalmedicine.42.82
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Internal Medicine

Related search

212. Disease Modeling of Late-Onset Pompe Disease-Specific Induced Pluripotent Stem Cells

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Cyclophosphamide Versus Placebo in Scleroderma Lung Disease

New England Journal of Medicine
Medicine
2006English

Huntington's Disease: Prenatal Screening for Late Onset Disease.

Journal of Medical Ethics
ArtsHumanitiesLegal AspectsHealth PolicyHealthEthicsIssues
1992English

A Case of Late-Onset Gemcitabine Lung Toxicity

Clinical Medicine Insights: Oncology
Oncology
2011English

Molecular Analysis of Late Onset Huntington's Disease.

Journal of Medical Genetics
Genetics
1993English

Adult Onset Lung Disease Following Transient Disruption of Fetal Stretch-Induced Differentiation

Respiratory Research
PulmonaryRespiratory Medicine
2009English

Early-Onset Versus Late-Onset Crohn's Disease: An Italian Cohort Study

United European Gastroenterology Journal
OncologyGastroenterology
2019English

Refsum Disease Presenting With a Late-Onset Leukodystrophy

JIMD Reports
Internal MedicineGeneticsMolecular BiologyBiochemistryEndocrinologyMetabolismDiabetes
2014English

Enzyme Replacement Therapy for Late-Onset Pompe Disease

Cochrane Database of Systematic Reviews
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy